Meeting Sites Where They Are: A Connected, Intelligence-Powered Operating Model
Meeting Sites Where They Are: A Connected, Intelligence-Powered Operating Model This on-demand webinar, presented by ICON, Advarra, and Fierce Pharma,
Sponsor
Why Do Clinical Trial Startup Delays Still Happen Despite More Technology?
Clinical trial study startup has become increasingly technology-enabled, yet sponsors, contract research organizations (CROs), and research sites still face persistent
How Amendment Intelligence Helps Reduce Avoidable Protocol Revisions
Clinical development teams can use operational and institutional review board (IRB) data to identify protocol-design risks before those risks trigger
Improving Clinical Trial Site Collaboration with Connected Study Startup Workflows
Clinical trial study startup requires constant coordination across sponsors, contract research organizations (CROs), research sites, and institutional review boards (IRBs).
21 CFR Part 11 and Good Clinical Practice Requirements Explained
Clinical research increasingly depends on electronic systems to support core trial documentation, data handling, and regulated workflows. That shift has
Unlocking Unstructured Data with AI for Optimized Protocol Development
Unlocking Unstructured Data with AI for Optimized Protocol Development In this podcast episode, Mike Eckrote, Senior Vice President of Strategic
A Practical Checklist for Building Confidence in Site Selection
How operational insight, performance data, and patient access signals can strengthen clinical trial site decisions Choosing the right sites can
Sponsor’s Guide to IRB Approval (Part VI): After IRB Approval: Compliance, Multi-Site Oversight, and Turning Review into a Strategic Advantage
IRB approval is a critical milestone in clinical research, but it isn’t the end of the oversight process. For sponsors, approval marks
London Innovation Summit: Let your network know you’ll be there!
Heading to the Advarra Innovation Summit in London? Share the news and encourage your peers and partners to join you!
Sponsor’s Guide to IRB Approval (Part V): How to Speed Up IRB Approvals
Institutional review board (IRB) approval is a critical milestone in clinical research, but it can also become a source of
Why Should Local IRBs and HRPPs Collaborate with External IRBs?
Multisite research and clinical trials increasingly rely on a single IRB (sIRB) for review. This increase reflects federal mandates, sponsor expectations, and the operational realities of modern multisite or cooperative research. For institutions with a local
Sponsor’s Guide to IRB Approval (Part IV): Preparing IRB Documents That Prevent Delays
A strong protocol and well-drafted consent form are essential, but they are not enough on their own to support a